Marinus pharmaceuticals inc (MRNS)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-18,672

-15,409

-13,806

-12,423

-12,483

-10,112

-11,110

-9,505

-5,999

-4,738

-4,170

-4,552

-5,438

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,216

-

-4,962

-5,268

-7,007

-3,607

-1,668

-3,323

-2,235

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

84

83

83

76

36

33

29

34

31

91

13

13

9

7

7

7

2

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

4

2

-2

2

2

3

Stock-based compensation expense

1,876

1,234

1,339

1,263

1,836

1,143

1,170

1,348

1,127

629

732

772

747

801

800

737

739

740

597

388

383

435

216

24

23

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-795

31

-428

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

6

-2

-

-

-

-

Loss on disposal of fixed assets

-

0

0

0

-42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash lease expense

62

59

59

61

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash lease liability

95

101

-89

-88

-55

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium on investments

-1

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

0

0

2

2

2

1

2

2

-

-

-

-

-

-

-

-

Amortization of discount on investments

-

-

-

-

-

5

23

26

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

-258

1,382

-997

248

847

27

150

-660

720

396

-101

-232

716

-342

132

-2,241

1,055

2,207

-1,479

326

-107

2,676

-478

-286

-568

Accounts payable and accrued expenses

2,259

-932

-582

2,642

-238

-190

3,277

1,761

-563

-41

204

-831

-1,453

-1,185

-672

1,892

-664

1,504

-61

-464

2,561

1,193

-1,343

591

944

Net cash used in operating activities

-14,037

-16,233

-12,020

-8,716

-11,664

-9,158

-6,807

-5,728

-6,149

-4,480

-3,123

-4,364

-6,849

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,082

-

-5,902

-5,226

-3,952

-1,968

-3,107

-2,389

-1,125

Cash flows from investing activities
Maturities of short-term investments

1,737

1,994

0

0

5,000

-

-

-

-

496

248

1,440

1,738

249

1,490

1,492

1,243

-

-

-

-

-

-

-

-

Deposit on property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

-

-

-

-

-

-

-

-

Purchases of short-term investments

8,433

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

744

5,221

249

1,491

-

-

-

-

Deposit on property and equipment

-

-

-

-74

80

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

1

30

18

288

52

77

-2

0

8

258

49

17

126

1

237

383

23

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-6,697

1,964

-255

-2,696

4,868

14,923

5,002

0

-8

238

-24,693

1,423

1,612

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,190

-

-4,972

-352

-1,491

-

-

-

-

Cash flows from financing activities
Proceeds from exercise of stock options

312

0

32

0

65

-

-

-

-

-

-

-

-

1

0

0

123

0

139

34

200

100

0

0

28

Financing costs

195

-

50

0

148

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments of notes payable

-

-

-

-

-

-

-

-

-

0

3,497

875

875

918

1,001

127

82

-

-

-

-

-

-

-

-

Proceeds from equity offerings, net of offering costs

-

-

-

-

-

-

-

-

-

-46

49,312

771

2,510

0

0

-25

-142

-

-

-

-

-

-

-

-

Repayments of short-term bank borrowings

-

-

-

-

-

0

0

0

193

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,110

-110

Net cash provided by/(used in) financing activities

117

68,069

-18

0

-83

42,300

0

14

-193

243

45,815

-104

1,635

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-20,617

53,784

-12,277

-11,412

-6,879

48,065

-1,805

-5,714

-6,350

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-3,045

-3,602

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-101

-

-32

34

200

4,616

41,796

1,975

-82

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,993

-

-10,906

-5,544

-5,243

2,615

38,689

-414

-1,207

Supplemental disclosure of cash flow information
Cash paid for interest

-

-

-

-

-

-

-

-

-

0

22

75

87

-

-

-

-

-

-

-

-

-

-

-

-

Accrued equity offering costs

-

-

-

-

-

-

-

-

-

-

-

-

50

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

120

-

118

116

114

-

-

-

-

Payment on notes payable in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

43

-

-

-

-

-

-

-

-

Property and equipment in accounts payable and accrued expenses

-

-

-

-

48

-

-

-

-

-

-

-

17

128

-221

-151

378

-

-

-

-

-

-

-

-

Operating lease liability

-

0

0

0

3,357

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating right-of-use asset

-

0

0

0

2,458

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-